Hidradenitis Suppurativa: Sonelokimab Shows Promise in Study
Sonelokimab is a novel humanized nanobody that selectively binds to interleukin (IL)-17A and IL-17F.
Stay updated with breaking news from Abscess. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sonelokimab is a novel humanized nanobody that selectively binds to interleukin (IL)-17A and IL-17F.
Treatment with the topical JAK inhibitor reduced abscess and inflammatory nodules in a phase 2 randomized, controlled trial in patients with mild hidradenitis suppurativa.
Several drugs should be avoided or used with caution because of potential risks during pregnancy, a dermatologist told colleagues.
A manager suffered panic attacks and developed a stomach abscess that required surgery after years of abuse from his employer including being repeatedly...
Skin conditions both specific and nonspecific to IBD are prevalent in children and adolescents with IBD, with infectious conditions being the most common.